Tanguy Seiwert

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Neil Gross

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Konrad Klinghammer

charité university hospital

GERMANY

View details

Hyunseok Kang

Associate Professor of Clinical Medicine

University of California, San Francisco

UNITED STATES

View details

Barbara Burtness

Professor

Yale University School of Medicine

UNITED STATES

View details

Mercedes Porosnicu

Wake Forest School of Medicine

UNITED STATES

View details

Charu Aggarwal

University of Pennsylvania

UNITED STATES

View details

Kevin Harrington

Head of Division of Radiotherapy and Imaging

Institute of Cancer Research

UNITED KINGDOM

View details

Lisa M. Rooper

Johns Hopkins University School of Medicine

UNITED STATES

View details

Gypsyamber DSouza

Professor

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES

View details

Missak Haigentz

Professor of Medicine and Chief, Thoracic and Head & Neck Medical Oncology

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tanguy Seiwert

Research Interests

Explore related searches

Contact this professor

Articles (13)

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Lower survival for surgical treatment of human papillomavirus–related oropharynx cancer at community cancer centers

Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?

Clinical Uncertainties of Circulating Tumor DNA in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma in the Absence of National Comprehensive Cancer Network Guidelines

Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma

The role of macrophages in the tumor microenvironment and tumor metabolism

Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Spontaneous regression of an human papillomavirus‐positive oropharyngeal squamous cell carcinoma

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma.

Reply to “Guarantee‐time bias in studies on the relationship between immune‐related adverse events and antitumor activity”

Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?

Time to Debunk an Urban Myth? The “Abscopal Effect” With Radiation and Anti–PD-1

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab‐resistant head and neck cancer: The MAESTRO study

Collaborators (10)

Neil Gross

Konrad Klinghammer

Hyunseok Kang

Barbara Burtness

Mercedes Porosnicu

Charu Aggarwal

Kevin Harrington

Lisa M. Rooper

Gypsyamber DSouza

Missak Haigentz

Make your next move.